UBXG Drops After 1-for-25 Split as Nasdaq Traders Watch the Stock

May 22, 2026
UBXG Drops After 1-for-25 Split as Nasdaq Traders Watch the Stock

New York, May 22, 2026, 17:05 EDT

  • UBXG ended at $3.12, dropping 3.26% as split-adjusted trading kicked off in the first regular session.
  • Nasdaq said the 1-for-25 reverse split and par-value change for U-BX took effect Friday.
  • U.S. stocks traded on a regular Friday schedule. Nasdaq will be shut Monday for Memorial Day.

U-BX Technology Ltd. shares closed down Friday. The Beijing insurance-tech firm started trading on Nasdaq after a 1-for-25 reverse stock split adjusted its share count.

UBXG’s quote jumped above $3 after its reverse split, up from under $1 before. That shift changes how the stock looks to brokers and retail traders. A reverse split boosts the per-share price by combining shares. It doesn’t add money to UBXG or affect how much of the company an investor owns.

Nasdaq Corporate Actions said U-BX will do a 1-for-25 reverse split and increase the par value of its Class A ordinary shares to $0.04 from $0.0016, starting Friday. The stock continues as UBXG.

UBXG ended the session at $3.120, down 3.26%. The stock changed hands between $3.000 and $3.569 on volume of around 33,990 shares, according to Webull. Over the last five days, MarketScreener showed the stock dropping 11.24%, and down 93.76% since Jan. 1, even after the reverse split.

U-BX said its reverse split will bring its Class A shares down to about 1.51 million from roughly 37.79 million, and Class B shares to around 0.31 million from 7.66 million. No fractional shares are planned. Investors owed a fractional share will get one share instead.

U-BX offers tech services for insurers and brokers in China. The company lists digital promotion tools, risk assessment products, and the “Magic Mirror” software, which it says helps figure out payout risk on auto insurance. Webull

Peer action in the space is hard to spot. Waterdrop Inc. and AIFU Inc. both work in China in insurance-technology and distribution. But UBXG’s jump on Friday came after changes to its own capital setup, not because of moves across the sector.

U-BX split up just after raising new cash. In April, the company sold 15.17 million units through a registered direct offering at $0.30 per unit before the split. Each unit gave the buyer a Class A share plus a warrant good for 0.3 of a Class A share. The deal was made under an SEC registration statement and went to picked investors.

UBXG slipped in thin trading late Friday even as the Dow Jones Industrial Average rose 0.58%, the S&P 500 added 0.37% and the Nasdaq Composite gained 0.19%, according to Reuters market data. Broader markets didn’t offer much support for what remains a single-stock story.

Nasdaq trading had ended before deadline. The exchange’s 2026 holiday schedule has Monday, May 25, off for Memorial Day, so Friday was the last U.S. stock market session before the three-day weekend.

The post-split price is up, but that doesn’t mean the business has turned. A split doesn’t bring in new money. The April offering and warrants may keep pressure on the stock if dilution remains the focus—current holders can end up with a smaller piece when more shares come out. Thin trading volume keeps the price at risk for swings on light orders.

Stock Market Today

  • Pro Medicus (PME) Share Price and Healthcare Sector Appeal on ASX
    May 22, 2026, 6:56 PM EDT. The Pro Medicus Ltd (ASX:PME) share price has dropped 42.5% since early 2025, prompting investor interest in healthcare stocks. Pro Medicus offers radiology IT software, including its flagship Visage platform that enables remote access to medical imaging, improving diagnostics. The S&P/ASX200 Healthcare Index has underperformed the broader market over five years but remains attractive due to three factors: stable, 'sticky' revenue streams unaffected by economic cycles; strong growth prospects, especially in healthcare IT and SaaS with projected 15%+ annual revenue growth; and rising ethical investing trends favoring essential healthcare services. PME trades at a price-to-sales ratio of 82.77x, slightly above its 5-year average, reflecting valuation considerations amid recent share price changes.